{
    "code": "60000945",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000945",
    "time": "2022-08-19 03:53:35",
    "許可證字號": "衛部菌疫輸字第000945號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/08\/05",
    "發證日期": "102\/08\/05",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000094501",
    "中文品名": "恩瑞舒針筒裝皮下注射劑125毫克",
    "英文品名": "Orencia (abatacept) Injection for subcutaneous use 125mg per syringe(125mg\/ml)",
    "適應症": "(1) 成人類風濕性關節炎：Orencia與methotrexate併用，適用於治療罹患高活動性暨惡化性類風濕性關節炎且未曾使用過methotrexate的成人病人。Orencia與methotrexate併用，用於治療罹患有中度至重度活動性類風溼性關節炎且對其他疾病修飾抗風濕病藥物 [包括methotrexate (MTX) 或一種腫瘤壞死因子 (TNF) 抑制劑] 反應不良或耐受性不佳的成人病人。\r\n(2) 重要用藥限制：Orencia不可與其他治療類風濕性關節炎 (RA) 的生物製劑含腫瘤壞死因子 (TNF) 抑制劑同時使用。",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 125毫克預充填注射針筒裝含安全護套 125毫克針筒裝注射劑，筆型注射器(內含單次使用預充填式注射器)",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "107\/08\/05",
    "主成分略述": "ABATACEPT",
    "限制項目": "02輸　入 1D須執行風險管理計畫",
    "申請商名稱": "1404501200  台灣必治妥施貴寶股份有限公司",
    "申請商地址": "台北市松山區健康路156號4樓、5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0826000  BRISTOL-MYERS SQUIBB HOLDINGS PHARMA, LTD., LIABILITY COMPANY",
            "製造廠廠址": "BO TIERRAS NUEVAS, ROUTE 686, KM. 2.3, MANATI, PUERTO RICO 00674, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FUS0508000  LONZA BIOLOGICS, INC.",
            "製造廠廠址": "101 INTERNATIONAL DRIVE PEASE INTERNATIONAL TRADEPORT PORTSMOUTH, NEW HAMPSHIRE, U.S. 03801",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FUS0885000  BRISTOL-MYERS SQUIBB COMPANY",
            "製造廠廠址": "38 JACKSON ROAD, DEVENS,MASSACHUSETTS 01434 ,USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200099700",
            "成分名稱": "ABATACEPT",
            "含量描述": "",
            "含量": "125.8750000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "皮下注射溶液；125 mg\/mL單劑預填充玻璃注射筒",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "衛部菌疫輸字第000945號 恩瑞舒針筒裝皮下注射劑125毫克 藥品外觀-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000945&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "恩瑞舒針筒皮下注射劑125毫克_仿單-109-03-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000945&Seq=007&Type=9"
        },
        {
            "title": "OrenciaAI_標籤_1423663-109-10-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000945&Seq=007&Type=8"
        },
        {
            "title": "OrenciaAI_外盒_1423241-109-10-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000945&Seq=006&Type=8"
        }
    ]
}